findmyKOL
Clinical trialNCT02376296CompletedObservational

Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients

SponsorSaladax Biomedical, Inc.Enrollment35Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Upmc Cancercenter - Beaver

    Beaver, Pennsylvania, United States

  • Upmc Cancercenter - Upper St. Clair

    Bethel Park, Pennsylvania, United States

  • Upmc Cancercenter - Horizon

    Farrell, Pennsylvania, United States

  • Arnold Palmer Cancer Center

    Greensburg, Pennsylvania, United States

  • Arnold Palmer Cancer Center - Oakbrook

    Greensburg, Pennsylvania, United States

  • Upmc Cancercenter - Greenville

    Greenville, Pennsylvania, United States

  • Upmc Cancercenter - Indiana

    Indiana, Pennsylvania, United States

  • Upmc Cancercenter at John P. Murtha Regional Cancer Center

    Johnstown, Pennsylvania, United States

  • Upmc Cancercenter - Mckeesport

    McKeesport, Pennsylvania, United States

  • Upmc Cancercenter - Monroeville

    Monroeville, Pennsylvania, United States

  • Arnold Palmer Medical Oncology - Mount Pleasant

    Mount Pleasant, Pennsylvania, United States

  • Upmc Cancercenter - New Castle

    New Castle, Pennsylvania, United States

  • Upmc Cancercenter - Hillman Cancer Center

    Pittsburgh, Pennsylvania, United States

  • Upmc Cancercenter - Passavant Hoa

    Pittsburgh, Pennsylvania, United States

  • Upmc Cancercenter - Passavant Oha

    Pittsburgh, Pennsylvania, United States

  • Upmc Cancercenter - St. Margaret

    Pittsburgh, Pennsylvania, United States

  • Upmc Cancercenter - Northwest

    Seneca, Pennsylvania, United States

  • Upmc Cancercenter - Uniontown

    Uniontown, Pennsylvania, United States

  • Upmc Cancercenter - Washington

    Washington, Pennsylvania, United States

  • Upmc Cancercenter - Jefferson

    West Mifflin, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2015
Primary completion
10 Feb 2018
Completion
10 Feb 2018
Last update posted
17 Feb 2022
Registered enrollment
35
Registry id
NCT02376296

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.